Home › Funds › Seven Fleet Capital Management LP › CCCC
Seven Fleet Capital Management LP position in CCCC
C4 THERAPEUTICS INC · Health Care
Seven Fleet Capital Management LP reported holding 381,169 shares of CCCC (C4 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 0.29% of its reported portfolio and ranking #43 among its reported holdings. Seven Fleet Capital Management LP has disclosed CCCC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Seven Fleet Capital Management LP's CCCC position evolved
Seven Fleet Capital Management LP first disclosed a stake in CCCC in Q1 2026 at 57,076 shares (US$150K). The position peaked in Q2 2026 at 381,169 shares, worth US$1.8M. Across 2 filings, Seven Fleet Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 381,169 shares valued at US$1.8M — an increase of 324,093 shares quarter over quarter.. Notable position changes include a 568% increase in Q2 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 57.08K | $150.11K | New |
| Q2 2026 | 381.17K | $1.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CCCC and 13F data
CCCC (C4 THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in CCCC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$37.4M), Lynx1 Capital Management LP (US$34.2M), Bain Capital Life Sciences Investors, LLC (US$33.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CCCC
- RA CAPITAL MANAGEMENT, L.P. 8.00M sh · $37.36M · Q2 2026
- Lynx1 Capital Management LP 7.33M sh · $34.22M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 7.17M sh · $33.49M · Q2 2026
- Soleus Capital Management, L.P. 3.38M sh · $15.78M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 3.03M sh · $14.16M · Q2 2026
- Ikarian Capital, LLC 2.43M sh · $11.36M · Q2 2026
- Patient Square Capital LP 1.61M sh · $7.51M · Q2 2026
- HighVista Strategies LLC 1.35M sh · $6.30M · Q2 2026
- Velan Capital Investment Management LP 570.00K sh · $2.66M · Q2 2026
- Squadron Capital Management LLC 400.00K sh · $1.87M · Q2 2026
More on Seven Fleet Capital Management LP
FAQ
How long has Seven Fleet Capital Management LP held CCCC?
Seven Fleet Capital Management LP has disclosed CCCC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Seven Fleet Capital Management LP's current position in CCCC?
As of Q2 2026, Seven Fleet Capital Management LP holds 381.17K shares of CCCC (C4 THERAPEUTICS INC), valued at $1.78M, representing 0.29% of its reported portfolio and ranking #43.
Has Seven Fleet Capital Management LP been buying or selling CCCC?
In the latest 13F filing (Q2 2026), Seven Fleet Capital Management LP increased its position in CCCC. The position peaked in Q2 2026 at 381.17K shares.
Which other funds hold CCCC?
Other major institutional holders of CCCC include RA CAPITAL MANAGEMENT, L.P., Lynx1 Capital Management LP, Bain Capital Life Sciences Investors, LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.